Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
184 participants
INTERVENTIONAL
2014-07-31
2015-07-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
* The mean duration of second stage in nulliparas as defined by the American college of obstetricians and gynecologists (ACOG) is 54 minutes
* Epidural anesthesia is a known cause for prolongation of the second stage of labor. Prolonged second stage in nullipara women with epidural is defined as more than 3 hours, and more than 2 hours in those without epidural.
* Although perinatal outcome is not compromised with a prolonged second stage , there is evidence that maternal morbidities such as perineal trauma, chorioamnionitis ,instrumental delivery and postpartum hemorrhage increase with prolonged second stage
* Another effect of epidural anesthesia during labor is urinary retention and a need for catheterization.
* Full bladder may behave as a tumor previa and interfere to fetal head descent in the birth canal, increasing by that the duration of the second stage.
* This study aims to investigate the effect of intermittent versus continuous catheterization on the duration of the second stage of labor
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Urinary Retention After Vaginal Delivery With Epidural Anesthesia.
NCT02865551
Intracutaneous Sterile Water Injections
NCT01513447
Time of Oxytocin Initiation at 2nd Stage of Labor and Adverse Outcomes
NCT06181396
Role of Intrapartum Ultrasound in Instrumental Delivery
NCT02899481
Head-perineum Distance and Delivery Mode
NCT04771091
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
intermittent urinary catheterization
nullipara women with epidural anaesthesia who pose urination difficulty will receive intermittent catheterization
urinary catheterization
nullipara women with epidural anaesthesia who pose urination difficulty will be randomize to receive intermittent or continuous urinary catheterization.
continuous urinary catheter
nullipara women with epidural anaesthesia who pose urination difficulty will receive continuous catheterization
urinary catheterization
nullipara women with epidural anaesthesia who pose urination difficulty will be randomize to receive intermittent or continuous urinary catheterization.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
urinary catheterization
nullipara women with epidural anaesthesia who pose urination difficulty will be randomize to receive intermittent or continuous urinary catheterization.
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Gestational age 24-42 weeks
* epidural anaesthesia
* Vertex presentation
* Singleton
18 Years
45 Years
FEMALE
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Raed Salim
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Raed Salim
MD
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
raed salim, MD
Role: STUDY_DIRECTOR
Dep. OB/GYN, HaEmek Medical Center, Afula, Israel
abeer suleiman, MD
Role: PRINCIPAL_INVESTIGATOR
Dep. OB/GYN, HaEmek Medical Center, Afula, Israel
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Dep. OB/GYN, HaEmek Medical Center
Afula, , Israel
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
45-14-EMC
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.